The Major Pharmaceutical Trade Show Returns to Shanghai in June 2026

The anticipated CPHI & PMEC China 2026 will occur from June 16 to 18 at the Shanghai New International Expo Centre (SNIEC). Building upon the success of previous editions, this key global event in the pharmaceutical industry promises to be a significant gathering for professionals and corporations alike.

As the largest pharmaceutical trade show in Asia, CPHI & PMEC China 2026 is expected to attract over 110,000 attendees from various sectors within the pharmaceutical field and will feature more than 3,600 exhibitors, showcasing a wide range of products and solutions that drive modern medicine. This event underscores China's prominent role as a hub for pharmaceutical ingredients manufacturing, making it an essential marketplace for global products that fuel medical solutions worldwide.

Orhan Caglayan, Executive Vice President of Pharmaceutical Portfolio at Informa Markets, highlighted the rapid pace of innovation in China. He stated, "The growth of CPHI & PMEC China reflects the remarkable innovation ecosystem in the country and solidifies its position as an optimal location for sourcing suppliers, optimizing supply chains, and establishing strategic partnerships. The 2026 edition of the trade show is a testament to the resilience and forward-looking vision of the pharmaceutical industry."

The upcoming edition will showcase several expanded zones, including pavilions dedicated to traditional Chinese medicine and presentations featuring next-generation pharmaceutical ingredients. This dual focus emphasizes both the cultural richness of traditional components and the cutting-edge pharmaceutical technologies that enhance health solutions.

New exhibitors, including specialized areas for innovative packaging technologies and intelligent laboratory spaces, will enhance the event's comprehensive offering. Participants will gain access to the largest base of pharmaceutical machinery producers in Asia, experiencing live equipment demonstrations, technical seminars, and networking opportunities. Programs are designed to connect international buyers directly with leading suppliers through matchmaking initiatives and factory visits.

The conference will host over 100 workshops and educational sessions featuring more than 700 experts. These sessions will offer unparalleled insights into market trends and technical knowledge, helping attendees remain at the forefront of rapid innovations in drug research, biotechnology developments, and machinery applications.

Organizers encourage visitors to take advantage of this unique global platform. Attendees can explore opportunities to connect with Chinese manufacturers, learn more about traditional medicine components and natural extracts, evaluate pharmaceutical machinery for production needs, and establish collaborations with contract manufacturers. Additionally, participants can broaden their network, gain expertise, and keep current with trends in pharmaceutical innovation.

For more information and registration details, please visit CPHI China 2026.
CPHI China Image

In conclusion, the CPHI & PMEC China 2026 is set to be an indispensable event for those involved in the pharmaceutical sector, providing remarkable opportunities to innovate and collaborate within a densely connected marketplace.